Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Net income | -$405M | $1.51B | $92.0M | $696M | $585M | $11.0M |
| EPS (diluted) | $7.16 | $7.16 | $0.32 | $2.48 | $2.09 | $0.04 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $675M | -$639M | $1.11B | $1.38B | $1.90B | $592M |
| Share buybacks | $47.0M | $12.0M | $56.0M | $32.0M | $0.00 | $0.00 |
| Dividends paid | $340M | $502M | $738M | $823M | $1.01B | $784M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $191M | $377M | $251M | $231M | $296M | $208M |
| Total assets | — | $17.2B | $16.1B | $15.5B | $14.2B | $13.7B |
| Total liabilities | — | $9.50B | $9.11B | $8.62B | $7.60B | $7.88B |
| Long-term debt | — | $9.14B | $8.69B | $8.19B | $7.35B | $7.63B |
| Shareholders' equity | $3.10B | $7.73B | $7.01B | $6.85B | $6.62B | $5.85B |
| Retained earnings | — | -$1.93B | -$2.60B | -$2.59B | -$2.66B | -$3.35B |
| Shares (wtd avg diluted) | 212M | 212M | 284M | 280M | 280M | 280M |
Every figure is extracted from FS KKR Capital Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.